Urist Marshall (CIK 1838139) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell RPRX (9,099 shares), Sell RPRX (9,098 shares), Sell RPRX (13,684 shares), Sell RPRX (13,684 shares), Buy RPRX (18,197 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 9,099 | $508,454 |
| 2026-06-25 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 9,098 | $502,067 |
| 2026-05-21 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 13,684 | $721,838 |
| 2026-05-15 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 13,684 | $726,137 |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Buy | 18,197 | $0 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Buy | 19,970 | $0 |
| 2026-02-02 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $821,800 |
| 2026-01-26 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $805,200 |
| 2026-01-20 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $790,400 |
| 2026-01-13 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $815,600 |
| 2026-01-06 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $769,600 |
| 2025-12-29 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $786,400 |
| 2025-12-22 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $767,600 |
| 2025-12-17 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 20,000 | $766,400 |
| 2025-12-09 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 23,334 | $913,526 |
| 2025-12-09 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 18,242 | $714,174 |
| 2025-12-03 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 23,333 | $931,687 |
| 2025-12-03 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Sell | 18,242 | $727,856 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Buy | 4,626 | $0 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Buy | 160,000 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Buy | 2,772 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | Buy | 36,484 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02